166 related articles for article (PubMed ID: 25856786)
1. Cognitive function in Chinese prostate cancer patients on androgen-deprivation therapy: A cross-sectional study.
Yang J; Zhong F; Qiu J; Wang K
Asia Pac J Clin Oncol; 2015 Dec; 11(4):277-81. PubMed ID: 25856786
[TBL] [Abstract][Full Text] [Related]
2. Dissociation of event-based prospective memory and time-based prospective memory in patients with prostate cancer receiving androgen-deprivation therapy: a neuropsychological study.
Yang J; Zhong F; Qiu J; Cheng H; Wang K
Eur J Cancer Care (Engl); 2015 Mar; 24(2):198-204. PubMed ID: 25711542
[TBL] [Abstract][Full Text] [Related]
3. Effects of long-term androgen deprivation therapy on cognitive function over 36 months in men with prostate cancer.
Alibhai SM; Timilshina N; Duff-Canning S; Breunis H; Tannock IF; Naglie G; Fleshner NE; Krahn MD; Warde P; Marzouk S; Tomlinson GA
Cancer; 2017 Jan; 123(2):237-244. PubMed ID: 27583806
[TBL] [Abstract][Full Text] [Related]
4. Cognitive functioning in men receiving androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis.
McGinty HL; Phillips KM; Jim HS; Cessna JM; Asvat Y; Cases MG; Small BJ; Jacobsen PB
Support Care Cancer; 2014 Aug; 22(8):2271-80. PubMed ID: 24859915
[TBL] [Abstract][Full Text] [Related]
5. The impact of long-term androgen deprivation therapy on cognitive function and socioeconomic decision making in prostate cancer patients.
Holtfrerich SKC; Knipper S; Purwins J; Castens J; Beyer B; Schlomm T; Diekhof EK
Psychooncology; 2020 Aug; 29(8):1338-1346. PubMed ID: 32539186
[TBL] [Abstract][Full Text] [Related]
6. Cognitive and neurobehavioral symptoms in patients with non-metastatic prostate cancer treated with androgen deprivation therapy or observation: A mixed methods study.
Wu LM; Tanenbaum ML; Dijkers MP; Amidi A; Hall SJ; Penedo FJ; Diefenbach MA
Soc Sci Med; 2016 May; 156():80-9. PubMed ID: 27019142
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of androgen deprivation therapy in prostate cancer patients.
Basaria S; Lieb J; Tang AM; DeWeese T; Carducci M; Eisenberger M; Dobs AS
Clin Endocrinol (Oxf); 2002 Jun; 56(6):779-86. PubMed ID: 12072048
[TBL] [Abstract][Full Text] [Related]
8. Cognitive problems in patients on androgen deprivation therapy: a qualitative pilot study.
Wu LM; Diefenbach MA; Gordon WA; Cantor JB; Cherrier MM
Urol Oncol; 2013 Nov; 31(8):1533-8. PubMed ID: 22975107
[TBL] [Abstract][Full Text] [Related]
9. Does androgen deprivation impact associations between cognition and strength, fitness and function in community-dwelling men with prostate cancer? A cross-sectional study.
Mundell NL; Owen PJ; Dalla Via J; Macpherson H; Daly RM; Fraser SF
BMJ Open; 2021 Dec; 11(12):e058478. PubMed ID: 36415046
[TBL] [Abstract][Full Text] [Related]
10. Course and Predictors of Cognitive Function in Patients With Prostate Cancer Receiving Androgen-Deprivation Therapy: A Controlled Comparison.
Gonzalez BD; Jim HS; Booth-Jones M; Small BJ; Sutton SK; Lin HY; Park JY; Spiess PE; Fishman MN; Jacobsen PB
J Clin Oncol; 2015 Jun; 33(18):2021-7. PubMed ID: 25964245
[TBL] [Abstract][Full Text] [Related]
11. Cognitive effects of long-term androgen deprivation therapy in older men with prostate cancer.
Pergolizzi D; Flaherty KR; Saracino RM; Root JC; Schofield E; Cassidy C; Katheria V; Patel SK; Dale W; Nelson CJ
Psychooncology; 2024 Mar; 33(3):e6336. PubMed ID: 38520472
[TBL] [Abstract][Full Text] [Related]
12. Androgen Deprivation Therapy and Cognitive Function in Prostate Cancer.
Kluger J; Roy A; Chao HH
Curr Oncol Rep; 2020 Feb; 22(3):24. PubMed ID: 32048059
[TBL] [Abstract][Full Text] [Related]
13. Depressive symptoms are found to be potential adverse effects of androgen deprivation therapy in older prostate cancer patients: A 15-month prospective, observational study.
Zhang Z; Yang L; Xie D; Shi H; Li G; Yu D
Psychooncology; 2017 Dec; 26(12):2238-2244. PubMed ID: 28474429
[TBL] [Abstract][Full Text] [Related]
14. Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy.
Basaria S; Muller DC; Carducci MA; Egan J; Dobs AS
Cancer; 2006 Feb; 106(3):581-8. PubMed ID: 16388523
[TBL] [Abstract][Full Text] [Related]
15. Cognitive and mood changes in men undergoing intermittent combined androgen blockade for non-metastatic prostate cancer.
Cherrier MM; Aubin S; Higano CS
Psychooncology; 2009 Mar; 18(3):237-47. PubMed ID: 18636420
[TBL] [Abstract][Full Text] [Related]
16. A 2-year prospective analysis of insomnia as a mediator of the relationship between androgen deprivation therapy and perceived cognitive function in men with prostate cancer.
Garland SN; Savard J; Eisel SL; Wassersug RJ; Rockwood NJ; Thoms J; Jim HSL; Gonzalez BD
Cancer; 2021 Dec; 127(24):4656-4664. PubMed ID: 34411294
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy.
Braga-Basaria M; Dobs AS; Muller DC; Carducci MA; John M; Egan J; Basaria S
J Clin Oncol; 2006 Aug; 24(24):3979-83. PubMed ID: 16921050
[TBL] [Abstract][Full Text] [Related]
18. Cognitive function in patients on androgen suppression: A prospective, multicentric study.
Morote J; Tabernero ÁJ; Álvarez-Ossorio JL; Ciria JP; Domínguez-Escrig JL; Vázquez F; Angulo J; López FJ; de La Iglesia R; Romero J;
Actas Urol Esp (Engl Ed); 2018 Mar; 42(2):114-120. PubMed ID: 29102054
[TBL] [Abstract][Full Text] [Related]
19. Systemic inflammation and symptomatology in patients with prostate cancer treated with androgen deprivation therapy: Preliminary findings.
Hoogland AI; Jim HSL; Gonzalez BD; Small BJ; Gilvary D; Breen EC; Bower JE; Fishman M; Zachariah B; Jacobsen PB
Cancer; 2021 May; 127(9):1476-1482. PubMed ID: 33378113
[TBL] [Abstract][Full Text] [Related]
20. Differences in time to disease progression do not predict for cancer-specific survival in patients receiving immediate or deferred androgen-deprivation therapy for prostate cancer: final results of EORTC randomized trial 30891 with 12 years of follow-up.
Studer UE; Whelan P; Wimpissinger F; Casselman J; de Reijke TM; Knönagel H; Loidl W; Isorna S; Sundaram SK; Collette L;
Eur Urol; 2014 Nov; 66(5):829-38. PubMed ID: 23932338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
